We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 21, H.C. Wainwright raised its price target on Lipocine Inc. (NASDAQ:LPCN) to $15 from $7 and maintained ...
SALT LAKE CITY, Nov. 4, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral ...
Second Drug Safety Monitoring Board (DSMB) meeting update planned for mid-January 2026 Topline results on track for the second quarter of 2026 SALT LAKE CITY, Dec. 16, 2025 /PRNewswire/ -- Lipocine ...
Assess a company's competitiveness in the job market with alternative data that tracks recruitment, job vacancies and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results